Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis.

BJOG · 2019 · PMC6771855 · PMID 31240854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

We were unable to assess health‐related quality of life and wellbeing scores, and any impact on loss of earnings associated with these serious adverse events, which may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.